Ann Lab Med.  2020 Mar;40(2):184-186. 10.3343/alm.2020.40.2.184.

First Report of Tenosynovitis Caused by Mycobacterium virginiense in Korea

• Oh S
• Lee KH
• Heo ST
• Kim GM
• Kim YR
• Yoo JR

• KMID: 2460919
• DOI: http://doi.org/10.3343/alm.2020.40.2.184

Abstract

No abstract available.

MeSH Terms

Korea*
Mycobacterium*
Tenosynovitis*

Figure

• 

  Fig. 1 Coronal T1-weighted, fat-suppressed, turbo spin-echo image showing effusion (arrowhead) and synovial proliferation on the flexor tendon sheath of the third finger of the left hand (white arrow).

• 

  Fig. 2 Phylogenetic tree constructed based on the rpoB gene of Mycobacterium virginiense. *The rpoB gene sequence of M. virginiense from the patient's tissue specimen is shown in bold (NTM patient-2019). Abbreviation: NTM, nontuberculous mycobacteria.

Reference

1. Lembo G, Goldstein EJ, Troum O, Mandelbaum B. Successful treatment of Mycobacterium terrae complex infection of the knee. J Clin Rheumatol. 2012; 18:359–362.

2. Vasireddy R, Vasireddy S, Brown-Elliott BA, Wengenack NL, Eke UA, Benwill JL, et al. Mycobacterium arupense, Mycobacterium heraklionense, and a newly proposed species, “Mycobacterium virginiense” sp. nov., but not Mycobacterium nonchromogenicum, as species of the Mycobacterium terrae complex causing tenosynovitis and osteomyelitis. J Clin Microbiol. 2016; 54:1340–1351.

3. Jung J, Yoo IY, Jhun BW, Koh WJ, Lee NY, Huh HJ. First isolation of Mycobacterium virginiense from a human pulmonary specimen. Ann Lab Med. 2019; 39:596–598.

4. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol. 2013; 30:2725–2729.

5. CLSI. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes. 2nd ed. CLSI M24-A2. Wayne, PA: Clinical and Laboratory Standards Institute;2011.

6. Smith DS, Lindholm-Levy P, Huitt GA, Heifets LB, Cook JL. Mycobacterium terrae: case reports, literature review, and in vitro antibiotic susceptibility testing. Clin Infect Dis. 2000; 30:444–453.

7. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007; 175:367–416.

8. Yu JR, Heo ST, Lee KH, Kim J, Sung JK, Kim YR, et al. Skin and soft tissue infection due to rapidly growing mycobacteria: case series and literature review. Infect Chemother. 2013; 45:85–93.